Lloyd I. Miller III Acquires 80,000 Shares of Intermolecular, Inc. (IMI) Stock
Intermolecular, Inc. (NASDAQ:IMI) major shareholder Lloyd I. Miller III purchased 80,000 shares of the business’s stock in a transaction on Thursday, June 22nd. The stock was acquired at an average price of $0.88 per share, with a total value of $70,400.00. Following the completion of the acquisition, the insider now directly owns 70,368 shares in the company, valued at approximately $61,923.84. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Shares of Intermolecular, Inc. (NASDAQ:IMI) traded down 2.5361% on Friday, reaching $0.9454. The company’s stock had a trading volume of 27,654 shares. The stock has a 50-day moving average of $0.88 and a 200 day moving average of $0.97. The stock’s market capitalization is $46.85 million. Intermolecular, Inc. has a 1-year low of $0.78 and a 1-year high of $1.64.
A hedge fund recently raised its stake in Intermolecular stock. Renaissance Technologies LLC increased its position in Intermolecular, Inc. (NASDAQ:IMI) by 8.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 826,866 shares of the semiconductor company’s stock after buying an additional 67,666 shares during the period. Renaissance Technologies LLC owned approximately 1.67% of Intermolecular worth $784,000 at the end of the most recent quarter. 38.93% of the stock is owned by institutional investors.
Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.
Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with MarketBeat.com's FREE daily email newsletter.